Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Notification of Proposed Production Activity; MSD International GMBH (Puerto Rico Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico, 64131 [2016-22480]
Download as PDF
Federal Register / Vol. 81, No. 181 / Monday, September 19, 2016 / Notices
Commission, grantee of FTZ 119,
submitted a notification of proposed
production activity to the FTZ Board on
behalf of Sick, Inc., within Subzone
119G, in Savage, Minnesota.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (81 FR 37570, June 10,
2016). The FTZ Board has determined
that no further review of the activity is
warranted at this time. The production
activity described in the notification is
authorized, subject to the FTZ Act and
the Board’s regulations, including
Section 400.14.
Dated: September 13, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016–22399 Filed 9–16–16; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–60–2016]
mstockstill on DSK3G9T082PROD with NOTICES
Foreign-Trade Zone (FTZ) 7—
Mayaguez, Puerto Rico; Notification of
Proposed Production Activity; MSD
International GMBH (Puerto Rico
Branch) LLC; Subzone 7G
(Pharmaceuticals) Las Piedras, Puerto
Rico
MSD International GMBH (Puerto
Rico Branch) LLC (MSD), operator of
Subzone 7G, submitted a notification of
proposed production activity to the FTZ
Board for its facility within Subzone 7G,
in Las Piedras, Puerto Rico. The
notification conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.22) was
received on August 29, 2016.
MSD currently has authority to
produce certain pharmaceutical
products and their intermediates within
Subzone 7G. The current request would
add a finished pharmaceutical product
and foreign status materials/components
to the scope of authority. Pursuant to 15
CFR 400.14(b), additional FTZ authority
would be limited to the specific foreignstatus materials/components and
specific finished product described in
the submitted notification (as described
below) and subsequently authorized by
the FTZ Board.
Production under FTZ procedures
could exempt MSD from customs duty
payments on the foreign-status
materials/components used in export
production. On its domestic sales, MSD
would be able to choose the duty rate
during customs entry procedures that
VerDate Sep<11>2014
21:47 Sep 16, 2016
Jkt 238001
applies to finished ertugliflozin/
metformin pharmaceutical tablets for
the treatment of type-2 diabetes (duty
free) for the foreign-status materials/
components noted below and in the
existing scope of authority. Customs
duties also could possibly be deferred or
reduced on foreign-status production
equipment.
The materials/components sourced
from abroad include: Metformin
hydrochloride and jet-milled
ertugliflozin active ingredients (duty
rates 3.7% and 6.5%).
Public comment is invited from
interested parties. Submissions shall be
addressed to the FTZ Board’s Executive
Secretary at the address below. The
closing period for their receipt is
October 31, 2016.
A copy of the notification will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room
21013, U.S. Department of Commerce,
1401 Constitution Avenue NW.,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the FTZ
Board’s Web site, which is accessible
via www.trade.gov/ftz.
For further information, contact Diane
Finver at Diane.Finver@trade.gov or
(202) 482–1367.
Dated: September 13, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016–22480 Filed 9–16–16; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–552–801]
Certain Frozen Fish Fillets From the
Socialist Republic of Vietnam:
Preliminary Results and Partial
Rescission of the Antidumping Duty
Administrative Review; 2014–2015
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department preliminarily
determines that none of the mandatory
respondents in this review qualify for a
separate rate and are, therefore,
considered a part of the Vietnam-Wide
Entity for their exports of subject
merchandise exported to the United
States during the period of review
(‘‘POR’’) August 1, 2014, through July
31, 2015. If these preliminary results are
adopted in the final results, the
Department will instruct U.S. Customs
and Border Protection (‘‘CBP’’) to assess
antidumping duties on all appropriate
AGENCY:
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
64131
entries of subject merchandise during
the POR. Interested parties are invited to
comment on these preliminary results.
DATES: Effective September 19, 2016.
FOR FURTHER INFORMATION CONTACT:
Kenneth Hawkins or Javier Barrientos,
AD/CVD Operations, Office V,
Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 14th
Street and Constitution Avenue NW.,
Washington, DC 20230; telephone 202–
482–6491 or 202–482–2243,
respectively.
SUPPLEMENTARY INFORMATION:
Background
On September 30, 2014, the
Department initiated the 12th
administrative review of the
antidumping duty order on fish fillets
from Vietnam for the period August 1,
2014, through July 31, 2015.1 On May 4,
2016, the Department partially extended
the deadline for issuing the preliminary
results by 118 days.2 The revised
deadline for the preliminary results of
this administrative review is now
September 6, 2016.
Scope of the Order
The product covered by the order is
frozen fish fillets, including regular,
shank, and strip fillets and portions
thereof, whether or not breaded or
marinated, of the species Pangasius
Bocourti, Pangasius Hypophthalmus
(also known as Pangasius Pangasius)
and Pangasius Micronemus. These
products are classifiable under tariff
article code 0304.62.0020 (Frozen Fish
Fillets of the species Pangasius,
including basa and tra), and may enter
under tariff article codes 0305.59.0000,
1604.19.2100, 1604.19.3100,
1604.19.4100, 1604.19.5100,
1604.19.6100 and 1604.19.8100 of the
Harmonized Tariff Schedule of the
United States (‘‘HTSUS’’).3 Although
1 See Initiation of Antidumping and
Countervailing Duty Administrative Reviews, 80 FR
60356 (October 6, 2015).
2 See Memorandum to Christian Marsh, Deputy
Assistant Secretary, Antidumping and
Countervailing Duty Operations, through James C.
Doyle, Director, Office V, Antidumping and
Countervailing Duty Operations regarding, from,
Kenneth Hawkins, International Trade Compliance
Analyst, Antidumping and Countervailing Duty
Operations, ‘‘Certain Frozen Fish Fillets from the
Socialist Republic of Vietnam: Extension of
Deadline for Preliminary Results of 2014–2015
Antidumping Duty Administrative Review,’’ dated
May 4, 2016.
3 Until June 30, 2004 these products were
classifiable under HTSUS 0304.20.6030,
0304.20.6096, 0304.20.6043 and 0304.20.6057.
From July 1, 2004 until December 31, 2006 these
products were classifiable under HTSUS
0304.20.6033. From January 1, 2007 until December
E:\FR\FM\19SEN1.SGM
Continued
19SEN1
Agencies
[Federal Register Volume 81, Number 181 (Monday, September 19, 2016)]
[Notices]
[Page 64131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22480]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-60-2016]
Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification
of Proposed Production Activity; MSD International GMBH (Puerto Rico
Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico
MSD International GMBH (Puerto Rico Branch) LLC (MSD), operator of
Subzone 7G, submitted a notification of proposed production activity to
the FTZ Board for its facility within Subzone 7G, in Las Piedras,
Puerto Rico. The notification conforming to the requirements of the
regulations of the FTZ Board (15 CFR 400.22) was received on August 29,
2016.
MSD currently has authority to produce certain pharmaceutical
products and their intermediates within Subzone 7G. The current request
would add a finished pharmaceutical product and foreign status
materials/components to the scope of authority. Pursuant to 15 CFR
400.14(b), additional FTZ authority would be limited to the specific
foreign-status materials/components and specific finished product
described in the submitted notification (as described below) and
subsequently authorized by the FTZ Board.
Production under FTZ procedures could exempt MSD from customs duty
payments on the foreign-status materials/components used in export
production. On its domestic sales, MSD would be able to choose the duty
rate during customs entry procedures that applies to finished
ertugliflozin/metformin pharmaceutical tablets for the treatment of
type-2 diabetes (duty free) for the foreign-status materials/components
noted below and in the existing scope of authority. Customs duties also
could possibly be deferred or reduced on foreign-status production
equipment.
The materials/components sourced from abroad include: Metformin
hydrochloride and jet-milled ertugliflozin active ingredients (duty
rates 3.7% and 6.5%).
Public comment is invited from interested parties. Submissions
shall be addressed to the FTZ Board's Executive Secretary at the
address below. The closing period for their receipt is October 31,
2016.
A copy of the notification will be available for public inspection
at the Office of the Executive Secretary, Foreign-Trade Zones Board,
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW.,
Washington, DC 20230-0002, and in the ``Reading Room'' section of the
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
For further information, contact Diane Finver at
Diane.Finver@trade.gov or (202) 482-1367.
Dated: September 13, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016-22480 Filed 9-16-16; 8:45 am]
BILLING CODE 3510-DS-P